← all drugs
Activated Charcoal Oral Suspension
being discontinued · Other · Snapshot: 2026-10-09
- Manufacturers listed
- Padagis US LLC
- Machine-readable
- JSON for this drug
Presentations (5)
| Presentation | Company | Availability | Updated |
|---|---|---|---|
| Actidose, Oral Suspension, 208 mg/1 mL (NDC 0574-0520-76) | Padagis US LLC | unknown | 05/15/2026 |
| Actidose Aqua, Oral Suspension, 208 mg/1 mL (NDC 0574-0521-76) | Padagis US LLC | unknown | 05/15/2026 |
| Actidose Aqua, Oral Suspension, 208 mg/1 mL (NDC 0574-0521-74) | Padagis US LLC | unknown | 05/15/2026 |
| Actidose Aqua, Oral Suspension, 208 mg/1 mL (NDC 0574-0521-25) | Padagis US LLC | unknown | 05/15/2026 |
| Actidose, Oral Suspension, 208 mg/1 mL (NDC 0574-0520-74) | Padagis US LLC | unknown | 05/15/2026 |
History
Daily tracking of this drug began 2026-08-25 (the first day of the archive). No change to its FDA listing has been observed since.
Each daily snapshot is compared with the one before it; status changes, availability-wording revisions, and arrivals or removals are listed here. A change the FDA makes and reverses between two snapshots is not seen. Every daily record is kept in the public repository.
Not medical advice. ShortSupply republishes the FDA's drug-shortage data with history added. Talk to your pharmacist or prescriber about your situation — never change medication based on this site.